McKesson Ventures, LLC - Sep 30, 2022 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
10%+ Owner
Signature
/s/ David Schulte, Senior Vice President and Managing Director of MCKESSON VENTURES, LLC
Stock symbol
AUGX
Transactions as of
Sep 30, 2022
Transactions value $
-$20,312
Form type
4
Date filed
10/4/2022, 07:54 PM
Previous filing
Sep 30, 2022
Next filing
Oct 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Sale -$17.8K -12.2K -0.3% $1.46 3.99M Sep 30, 2022 Direct F1
transaction AUGX Common Stock Sale -$2.51K -1.78K -0.04% $1.41 3.99M Oct 3, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.42 to $1.55. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.34 to $1.51. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.